CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoid in North America
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date real-time information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
Infographics
Highlights of the data and analysis that can be found in our full-length market reports
NEW FORMAT
From February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
Daily news alerts
Our legal experts track the evolving regulation around the cannabinoid and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
5th December 2022
US - Michigan: House Bill (HB) 5871 has been passed by the Senate and now heads to the governor for final approval. HB 5871 would clarify what activities are allowed under growing and processing licences for medical cannabis and would allow spouses of certain government officials to apply for medical cannabis licences if certain conditions are met and an attestation is included with the application.5th December 2022
- US - New York: Assembly Bill A 9282 has been signed into law by governor Kathy Hochul. A 9282 requires the state agricultural commissioner to "consult and cooperate with" a hemp workgroup and hemp industry representatives over business development and promotion of the hemp industry.
5th December 2022
- US - Federal: President Joe Biden has signed into law the Medical Marijuana and Cannabidiol Research Expansion Act (HR 8454). Ostensibly, the bill is intended to increase research into cannabis and CBD by eliminating regulatory barriers to research. However, some in the industry fear that the bill would actually create more barriers in many cases. For example, the bill would appear to require Drug Enforcement Administration (DEA) registration to research CBD, whereas current law does not require DEA registration for researching hemp-derived CBD since it is not a controlled substance. HR 8454 also allows doctors to freely discuss the "potential harms and benefits" of medical cannabis with patients without fear of running afoul of the federal Controlled Substances Act.
2nd December 2022
- US - Federal: US Senator John Hickenlooper (Democrat, Colorado) formally introduced the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment (PREPARE) Act, which would be triggered if the federal government legalises cannabis. The bill would establish the Commission on the Federal Regulation of Cannabis to advise on a regulatory framework for cannabis modelled after alcohol regulation, though the Commission would not have rulemaking authority. The Commission would be required to hold a public comment period and hear from witnesses. A companion bill (HR 7513) was introduced in the House in April.
2nd December 2022
- Canada - Newfoundland: The province of Newfoundland and Labrador has lifted its ban on cannabis vaping products, but only for products that do not contain any flavours besides natural terpenes and cannabis flavour, press reports. The province banned cannabis vapes in 2019, and the reversal comes as an attempt to compete with illicit sales.
1st December 2022
US - Rhode Island: Recreational cannabis dispensaries can begin sales from today, 1st December. Rhode Island legalised recreational cannabis in May.
1st December 2022
US - Nevada: The Nevada Cannabis Compliance Board (CCB) has issued 20 prospective licences for cannabis consumption lounges that were determined via a lottery of applicants. Ten provisional licences were issued to social equity applicants (applicants who have been convicted of a cannabis offence, had a family member convicted of a cannabis offence, or who lived in an area impacted by a prohibitionist drug policy). Prospective licensees must still pass a suitability investigation by the CCB before their licences will be issued. Another 20 applicants were approved for consumption lounges that must be attached to a licensed operational cannabis dispensary.
30th November 2022
US - Ohio: State lawmakers are interested in passing medical cannabis reform, as committees in the state House of Representatives debate Senate Bill 261, press reports. SB 261 was passed by the Senate last December and would make major reforms to Ohio's medical cannabis programme by creating a new regulatory agency – the Division of Marijuana Control – increasing the number of medical cannabis dispensaries, and expanding qualifying conditions for doctors to prescribe cannabis for to include those “that the patient’s symptoms may reasonably be expected to be relieved from medical marijuana”. The legislative session ends at the end of December.
29th November 2022
Mexico: A court in Sonora has granted a citizen’s petition and ordered the Federal Commission for the Protection against Public Health Risks (Cofepris) to issue a permit to consume and cultivate recreational cannabis for personal use, press reports. No commercial activity is allowed under the order (called an amparo). While the regulatory landscape for cannabis in Mexico is very unsettled, the courts continue to grant amparos to companies and individuals for cannabis-related activities.
29th November 2022
Canada - Manitoba: A bill has been introduced that would eliminate the “social responsibility” tax on cannabis sales in Manitoba, which is currently 6%, imposed on cannabis retailers. The provincial government is in discussions with federal authorities to piggyback on the federal excise tax on cannabis by increasing the excise tax to CAD1, of which CAD0.75 would go to the provincial government, as in all other provinces, press reports. If passed, the social responsibility tax would be eliminated from 1st January 2023.
28th November 2022
- Canada: Health Canada has announced the members of its expert panel that will lead the mandatory review of the Cannabis Act to "provide independent, expert advice to both ministers on progress made towards achieving the Act's objectives and help identify potential areas for improving the functioning of the legislation". The panel of five will be chaired by Morris Rosenberg, who has been in various departments in the Canadian government for more than 30 years. Health Canada must submit a report on the review to both houses of Parliament within 18 months of the review beginning.
